---
figid: PMC5960455__12264_2018_219_Fig1_HTML
figlink: /pmc/articles/PMC5960455/figure/Fig1/
number: Fig. 1
caption: 'Role of WNT/beta-catenin signaling in gliomas. When the canonical WNT/β-catenin
  pathway is upregulated, binding of WNT to FZD leads to activation of DSH, which
  recruits the destruction complex to the plasma membrane. AXIN binds to the cytoplasmic
  tail of LRP5/6. WNT also binds LRP5/6. This initiates LRP phosphorylation and DSH-mediated
  FZD internalization. Activation of DSH leads to the inhibition of GSK-3β, which
  further reduces the phosphorylation and degradation of β-catenin. The β-catenin
  degradation complex AXIN/APC/GSK-3β is inactivated with the recruitment of AXIN
  to the plasma membrane. β-catenin phosphorylation is inhibited. Then, β-catenin
  accumulates into cytosol and translocates to the nucleus to bind the TCF–LEF co-transcription
  factors. This induces the canonical WNT-response gene transcription (c-Myc, cyclin
  D, PDK1, and MCT-1). The STAT3 signaling pathway upregulates the expression and
  transcriptional activity of β-catenin; in gliomas STAT3 is a tumor aggressiveness
  factor. In gliomas, overexpression of EGFR (a receptor tyrosine kinase: RTK) stimulates
  the PI3K/Akt pathway. PI3K/Akt signaling leads to the phosphorylation of GSK3β that
  leads to the nuclear translocation and stabilization of β-catenin. In the same way,
  the WNT/β-catenin pathway stimulates EGFR in gliomas. Akt signaling increases MMP-2
  and MMP-9 activity, which induces the invasion of malignant cells into healthy brain
  near the glioma. Akt signaling induces HIF-1α (hypoxia-inducible factor-1 alpha),
  which stimulates PDK1. Overexpression of WNT/β-catenin also stimulates PDK1. PDK1
  and Myc induce lactate dehydrogenase A (LDH-A), and cytosolic pyruvate is shunted
  into lactate through activation of LDH-A. Overexpression of MCT-1 exports lactate
  to the extracellular space. Lactate production activates angiogenesis. c-Myc-induced
  glutaminolysis supports mitochondrial integrity and the production of aspartate,
  and results in nucleotide biosynthesis. c-Myc and cyclin D stimulate the proliferation
  of gliomas.'
pmcid: PMC5960455
papertitle: 'Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR
  Gamma: A Potential Therapeutic Target in Gliomas.'
reftext: Alexandre Vallée, et al. Neurosci Bull. 2018 Jun;34(3):573-588.
pmc_ranked_result_index: '53673'
pathway_score: 0.9086115
filename: 12264_2018_219_Fig1_HTML.jpg
figtitle: Role of WNT/beta-catenin signaling in gliomas
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5960455__12264_2018_219_Fig1_HTML.html
  '@type': Dataset
  description: 'Role of WNT/beta-catenin signaling in gliomas. When the canonical
    WNT/β-catenin pathway is upregulated, binding of WNT to FZD leads to activation
    of DSH, which recruits the destruction complex to the plasma membrane. AXIN binds
    to the cytoplasmic tail of LRP5/6. WNT also binds LRP5/6. This initiates LRP phosphorylation
    and DSH-mediated FZD internalization. Activation of DSH leads to the inhibition
    of GSK-3β, which further reduces the phosphorylation and degradation of β-catenin.
    The β-catenin degradation complex AXIN/APC/GSK-3β is inactivated with the recruitment
    of AXIN to the plasma membrane. β-catenin phosphorylation is inhibited. Then,
    β-catenin accumulates into cytosol and translocates to the nucleus to bind the
    TCF–LEF co-transcription factors. This induces the canonical WNT-response gene
    transcription (c-Myc, cyclin D, PDK1, and MCT-1). The STAT3 signaling pathway
    upregulates the expression and transcriptional activity of β-catenin; in gliomas
    STAT3 is a tumor aggressiveness factor. In gliomas, overexpression of EGFR (a
    receptor tyrosine kinase: RTK) stimulates the PI3K/Akt pathway. PI3K/Akt signaling
    leads to the phosphorylation of GSK3β that leads to the nuclear translocation
    and stabilization of β-catenin. In the same way, the WNT/β-catenin pathway stimulates
    EGFR in gliomas. Akt signaling increases MMP-2 and MMP-9 activity, which induces
    the invasion of malignant cells into healthy brain near the glioma. Akt signaling
    induces HIF-1α (hypoxia-inducible factor-1 alpha), which stimulates PDK1. Overexpression
    of WNT/β-catenin also stimulates PDK1. PDK1 and Myc induce lactate dehydrogenase
    A (LDH-A), and cytosolic pyruvate is shunted into lactate through activation of
    LDH-A. Overexpression of MCT-1 exports lactate to the extracellular space. Lactate
    production activates angiogenesis. c-Myc-induced glutaminolysis supports mitochondrial
    integrity and the production of aspartate, and results in nucleotide biosynthesis.
    c-Myc and cyclin D stimulate the proliferation of gliomas.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP5
  - LDHA
  - FZD2
  - MCTS1
  - FZD1
  - FZD4
  - FZD5
  - LRP6
  - WNT10B
  - MMP2
  - FZD6
  - MMP9
  - FZD8
  - FZD10
  - PIK3R4
  - PIK3CA
  - FZD3
  - PDHX
  - PDK1
  - PDK3
  - WNT8B
  - STAT3
  - WNT11
  - WNT2B
  - FZD7
  - FZD9
  - WNT4
  - WNT1
  - WNT2
  - WNT5A
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - PDK4
  - PDK2
  - AKT2
  - AKT3
  - WNT9A
  - DLAT
  - DLD
  - PDHA2
  - PDHA1
  - PDHB
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - APC
  - CTNNB1
  - MYC
  - AKT1
  - PIK3R6
  - PIK3R5
  - WNT10A
  - WNT5B
  - WNT3A
  - WNT16
  - WNT9B
  - CCND1
  - WNT3
  - Nucleotide
  - Lactate
  - TCA
  - Fatty acid
  - Cancer
genes:
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: LDH-A
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: MCT-1
  symbol: MCT-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCTS1
  entrez: '28985'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: MMP-2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: MMP-9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Fzd
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Beta-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
chemicals:
- word: Nucleotide
  source: MESH
  identifier: D009711
- word: Lactate
  source: MESH
  identifier: D019344
- word: TCA
  source: MESH
  identifier: C000589078
- word: Fatty acid
  source: MESH
  identifier: D005227
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
